Quantitative home-based assessment of Parkinson’s symptoms: The SENSE-PARK feasibility and usability study

Autor: Ferreira, Joaquim J, Godinho, Catarina, Santos, Ana T., Domingos, Josefa, Abreu, Daisy, Lobo, Raquel, Larsen, Frank Atle, Fagerbakke, Øyvind, Akeren, Ingvild, Wangen, Hilde, Serrano, Artur, Weber, Peter, Thoms, Andrea, Meckler, Stefan, Sollinger, Stefan, Uem, Janet van, Hobert, Markus A, Maier, Karin S, Matthew, Helen, Isaacs, Tom, Duffen, Joy, Graessner, Holm, Maetzler, Walter

Publikováno v: BMC Neurology (2015) 15:89

Externí odkaz: https://hdl.handle.net/10037/8847

Quantitative home-based assessment of Parkinson's symptoms: the SENSE-PARK feasibility and usability study.

Autor: Ferreira JJ; Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisbon, Portugal. cgcgodinho@gmail.com.; Laboratory of Clinical Pharmacology and Therapeutics, Faculty of Medicine, University of Lisbon, Lisbon, Portugal. cgcgodinho@gmail.com.; CNS - Campus Neurológico Sénior, Torres Vedras, Portugal. cgcgodinho@gmail.com., Godinho C; Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisbon, Portugal. cgcgodinho@gmail.com.; CNS - Campus Neurológico Sénior, Torres Vedras, Portugal. cgcgodinho@gmail.com.; Center for Interdisciplinary Research Egas Moniz (CiiEM), Cooperativa de Ensino Superior Egas Moniz, Monte de Caparica, Caparica, Portugal. cgcgodinho@gmail.com., Santos AT; Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisbon, Portugal. aa.teresa.ss@gmail.com., Domingos J; Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisbon, Portugal. domingosjosefa@gmail.com., Abreu D; Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisbon, Portugal. daideabreu@gmail.com., Lobo R; Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisbon, Portugal. raquel.jl.lobo@gmail.com., Gonçalves N; Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisbon, Portugal. nilzakarina@gmail.com., Barra M; Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisbon, Portugal. marciocbarra@gmail.com., Larsen F; NST-Norwegian Centre for Integrated Care and Telemedicine, University Hospital North Norway, Tromsø, Norway. Frank.Larsen@telemed.no., Fagerbakke Ø; NST-Norwegian Centre for Integrated Care and Telemedicine, University Hospital North Norway, Tromsø, Norway. oyvind.fagerbakke@framhelse.no., Akeren I; NST-Norwegian Centre for Integrated Care and Telemedicine, University Hospital North Norway, Tromsø, Norway. ingvild.akeren@framhelse.no., Wangen H; NST-Norwegian Centre for Integrated Care and Telemedicine, University Hospital North Norway, Tromsø, Norway. Hilde.wangen@framhelse.no., Serrano JA; NST-Norwegian Centre for Integrated Care and Telemedicine, University Hospital North Norway, Tromsø, Norway. jarturserrano@gmail.com.; Department of Clinical Medicine, Faculty of Health Sciences, The Arctic University of Norway, Tromsø, Norway. jarturserrano@gmail.com., Weber P; Hasomed GmbH, Magdeburg, Germany. weber.peter@hasomed.de., Thoms A; Hasomed GmbH, Magdeburg, Germany. andrea.thoms@hasomed.de., Meckler S; HSG-IMIT, Villingen-Schwenningen, Germany. stefan.meckler@hsg-imit.de., Sollinger S; AbilityNet, London, UK. stefan.sollinger@abilitynet.org.uk., van Uem J; Hertie Institute for Clinical Brain Research, Department of Neurodegeneration, Center of Neurology, University of Tuebingen, Tuebingen, Germany. janetvanuem@gmail.com.; DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. janetvanuem@gmail.com., Hobert MA; Hertie Institute for Clinical Brain Research, Department of Neurodegeneration, Center of Neurology, University of Tuebingen, Tuebingen, Germany. markus.hobert@med.uni-tuebingen.de.; DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. markus.hobert@med.uni-tuebingen.de., Maier KS; Hertie Institute for Clinical Brain Research, Department of Neurodegeneration, Center of Neurology, University of Tuebingen, Tuebingen, Germany. katrin-simone.maier@student.uni-tuebingen.de.; DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. katrin-simone.maier@student.uni-tuebingen.de., Matthew H; The Cure Parkinson's Trust, London, UK. helen@cureparkinsons.org.uk., Isaacs T; The Cure Parkinson's Trust, London, UK. tom@cureparkinsons.org.uk., Duffen J; The Cure Parkinson's Trust, London, UK. joy@cureparkinsons.org.uk., Graessner H; Institute for Medical Genetics and Applied Genomics, University of Tübingen, Tuebingen, Germany. holm.graessner@med.uni-tuebingen.de., Maetzler W; Hertie Institute for Clinical Brain Research, Department of Neurodegeneration, Center of Neurology, University of Tuebingen, Tuebingen, Germany. walter.maetzler@uni-tuebingen.de.; DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. walter.maetzler@uni-tuebingen.de.

Publikováno v: BMC neurology [BMC Neurol] 2015 Jun 10; Vol. 15, pp. 89. Date of Electronic Publication: 2015 Jun 10.